Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Guangji Pharmaceutical
Wuxue, Hubei, Chinaguangjipharm.com ↗
- Ownership
- Private
- Employees
- ~1398
- Development stage
- Other
01
Overview
Hubei Guangji Pharmaceutical is a leading producer of pharmaceutical raw materials, particularly riboflavin (Vitamin B2), as well as other fine chemicals and API products. The company's primary products include riboflavin, riboflavin-5-phosphate sodium, pyridoxine, and tinidazole, all of which are commercialized globally[1][3][5][7]. There are no disclosed clinical-stage pharmaceutical innovation programs.
- Therapeutic areas
- Infectious DiseasesMetabolic Disorders
- Modalities
- Small moleculeVitamin
- Industry
- Chemicals & Materials
Beyond the preview
Go deeper on Hubei Guangji Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hubei Guangji Pharmaceutical.